Identification and referral of patients with refractory epilepsy from the primary to the tertiary care interface in New South Wales, Australia.


Journal

Epilepsy & behavior : E&B
ISSN: 1525-5069
Titre abrégé: Epilepsy Behav
Pays: United States
ID NLM: 100892858

Informations de publication

Date de publication:
10 2020
Historique:
received: 08 01 2020
revised: 02 04 2020
accepted: 05 06 2020
pubmed: 9 7 2020
medline: 24 3 2021
entrez: 9 7 2020
Statut: ppublish

Résumé

This mixed-method feasibility study conducted in New South Wales (NSW), Australia, aimed to explore clinical practices around the identification of patients with refractory epilepsy and referral from primary care to Tertiary Epilepsy Centers. The perceptions of general practitioners, neurologists, and adults living with refractory epilepsy were considered. Fifty-two data collection events were achieved through 22 semi-structured interviews with six neurologists and 12 adults who currently have, or have had refractory epilepsy, and four family members, 10 clinical observations of patient consultations and 20 surveys with general practitioners. A thematic analysis was conducted on the qualitative data alongside assessment of observational fieldnotes and survey data. Two main themes emerged: 1) Patient healthcare pathways and care experiences highlighted the complex and deeply contextualized experiences of both patients and healthcare professionals, from first identification of people's seizures, in primary and community care settings, to referral to Tertiary Epilepsy Centers, shedding light on a fragmented, nonstandardized referral process, influenced by both individual and shared-care practices. 2) Factors impacting referrals and patient pathways indicated that onward referral to a Tertiary Epilepsy Center is affected by the knowledge, or the lack thereof, of healthcare professionals regarding treatment options. Barriers include limited person-centered care, shared decision-making, and refractory epilepsy education for healthcare professionals, which can delay patients' disease identification and can hinder speedy referral pathways and processes, in Australia for up to 17 years. In addition, person-centered communication around care pathways is affected by relationships between clinicians, patients, and family members. This study has identified a noticeable lack of standardized care across epilepsy-related healthcare sectors, which recognizes a need for developing and implementing clearer epilepsy-related guidelines and Continuing Professional Development in the primary and community care settings. This, however, requires greater collaboration and commitment in the primary, community, and tertiary care sectors to address the ongoing misconceptions around professional roles and responsibilities to optimize shared-care practices. Ultimately, prioritizing person-centered care on both patients' and professionals' agendas, in order to improve satisfaction with care experiences of people living with complex epilepsy.

Identifiants

pubmed: 32640412
pii: S1525-5050(20)30411-X
doi: 10.1016/j.yebeh.2020.107232
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107232

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Karen Hutchinson (K)

Australian Institute of Health Innovation, Level 6, 75 Talavera Road, Macquarie University, NSW 2109, Australia. Electronic address: karen.hutchinson@mq.edu.au.

Geoffrey Herkes (G)

University of Sydney, City Road, Camperdown, NSW 2006, Australia; Royal North Shore Hospital, Reserve Rd, St Leonards, NSW 2065, Australia. Electronic address: geoffrey.herkes@health.nsw.gov.au.

Patti Shih (P)

Australian Institute of Health Innovation, Level 6, 75 Talavera Road, Macquarie University, NSW 2109, Australia. Electronic address: patti.shih@uow.edu.au.

Emilie Francis-Auton (E)

Australian Institute of Health Innovation, Level 6, 75 Talavera Road, Macquarie University, NSW 2109, Australia. Electronic address: emilie.francis-auton@mq.edu.au.

Mia Bierbaum (M)

Australian Institute of Health Innovation, Level 6, 75 Talavera Road, Macquarie University, NSW 2109, Australia. Electronic address: mia.bierbaum@mq.edu.au.

Tayhla Ryder (T)

Australian Institute of Health Innovation, Level 6, 75 Talavera Road, Macquarie University, NSW 2109, Australia. Electronic address: tayhla.ryder@mq.edu.au.

Armin Nikpour (A)

University of Sydney, City Road, Camperdown, NSW 2006, Australia; Royal Prince Alfred Hospital, 50 Missenden Rd, Camperdown, NSW 2050, Australia. Electronic address: armin@sydneyneurology.com.au.

Andrew Bleasel (A)

University of Sydney, City Road, Camperdown, NSW 2006, Australia; Westmead Hospital, Corner Darcy and Hawkesbury Rd, Westmead, NSW 2145, Australia. Electronic address: andrew.bleasel@sydney.edu.au.

Chong Wong (C)

University of Sydney, City Road, Camperdown, NSW 2006, Australia; Westmead Hospital, Corner Darcy and Hawkesbury Rd, Westmead, NSW 2145, Australia. Electronic address: chong.wong@health.nsw.gov.au.

Sanjyot Vagholkar (S)

MQ Health General Practice, Macquarie University, NSW 2109, Australia. Electronic address: sanjyot.vagholkar@mq.edu.au.

Jeffrey Braithwaite (J)

Australian Institute of Health Innovation, Level 6, 75 Talavera Road, Macquarie University, NSW 2109, Australia. Electronic address: jeffrey.braithwaite@mq.edu.au.

Frances Rapport (F)

Australian Institute of Health Innovation, Level 6, 75 Talavera Road, Macquarie University, NSW 2109, Australia. Electronic address: frances.rapport@mq.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH